Accretion Pharmaceuticals Shareholders Approve Key Special Resolutions via Postal Ballot
Accretion Pharmaceuticals Ltd 路 Annual General Meeting 路 12 Oct 2026, 6:44 pm
Accretion Pharmaceuticals Shareholders Approve Key Special Resolutions via Postal Ballot Accretion Pharmaceuticals Limited announced the passing of all five special resolutions via postal ballot with 100% shareholder approval for valid votes cast during e-voting concluded on 9th Oct'26. Approved items include alterations to the Memorandum of Association, increased borrowing limits under Section 180(1)(c), creation of security/mortgages under Section 180(1)(a), revised limits for loans, guarantees, and securities to subsidiaries under Section 185, and enhanced loan, guarantee, and investment limits under Section 186 of the Companies Act, 2013. The company also submitted a revised scrutinizer's report rectifying minor typographical errors.
Original exchange filing (PDF)
More announcements from Accretion Pharmaceuticals Ltd
- Accretion Pharmaceuticals Limited has informed the Exchange about General Updates 路 16 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Investor Presentation 路 03 Nov 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 02 Nov 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 31, 2026, titled "Company Reports 25.83% Revenue Growth and 72.63% PAT Growth in H1 FY27 and Strong EBITDA Growth of 72.28%; EBITDA Margin Improves to 22.48%". 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has submitted to the Exchange, the unaudited financial results for the half year ended September 30, 2026. 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 31-Oct-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 31 Oct 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 31 Oct 2026
- Accretion Pharmaceuticals Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. 路 11 Oct 2026
